ILMN Stock: Price, Earnings History and SEC Filings
Illumina, Inc. (ILMN) last traded at $235.99, down 18.64% on the latest session and down 13.8% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.44 against an analyst estimate of $1.36, a beat of 5.9%.
$235.99 -18.64%
1 month-13.77%
52-week high$309.35
52-week low$112.65
Volume5.39M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ILMN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $1.44 | $1.36 | +5.88% |
| Jun 2026 | Jul 30, 2026 | $1.31 | $1.23 | +6.50% |
| Mar 2026 | Apr 30, 2026 | $1.15 | $1.05 | +9.52% |
| Dec 2025 | Feb 5, 2026 | $1.35 | $1.26 | +7.14% |
ILMN beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ILMN
SEC filing data is not available right now. You can search for ILMN on SEC EDGAR.
ILMN news
- Illumina (ILMN) Stock Falls After Q3 Results Lift GuidanceNov 1, 2026 · finance.yahoo.com
- Why Illumina (ILMN) shares are getting obliterated todayOct 31, 2026 · finance.yahoo.com
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Oct 31, 2026 · stocktwits.com
- Illumina (ILMN) Stock Stays Reasonable After Raised 2026 GuidanceOct 31, 2026 · finance.yahoo.com
- Illumina CEO on Q3 Results and Business OutlookOct 30, 2026 · finance.yahoo.com
- Illumina (ILMN) Lifts Outlook Following Q3 Results But Valuation Still Looks StretchedOct 30, 2026 · finance.yahoo.com
- Illumina Crashes As Tariffs, AI Woes Eat Into 157% Run-UpOct 30, 2026 · finance.yahoo.com
- Clinical Genomics Interpretation Platforms Global Market Report 2026 | Capitalize on AI and Cloud Growth Through 2030 with Thermo Fisher, Illumina, QIAGEN, and Tempus AIOct 30, 2026 · finance.yahoo.com
About Illumina, Inc.
Illumina, Inc. (ILMN) is a US-listed public company on Nasdaq.